JPS56135419A - Preventive and improver for radiation disorder - Google Patents
Preventive and improver for radiation disorderInfo
- Publication number
- JPS56135419A JPS56135419A JP3823580A JP3823580A JPS56135419A JP S56135419 A JPS56135419 A JP S56135419A JP 3823580 A JP3823580 A JP 3823580A JP 3823580 A JP3823580 A JP 3823580A JP S56135419 A JPS56135419 A JP S56135419A
- Authority
- JP
- Japan
- Prior art keywords
- bacterium
- oligosaccharides
- improver
- preventive
- gal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003449 preventive effect Effects 0.000 title abstract 3
- 230000005855 radiation Effects 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 6
- 241000186000 Bifidobacterium Species 0.000 abstract 4
- 229920001542 oligosaccharide Polymers 0.000 abstract 4
- 150000002482 oligosaccharides Chemical class 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000000936 intestine Anatomy 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 abstract 1
- 235000020256 human milk Nutrition 0.000 abstract 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000000644 propagated effect Effects 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3823580A JPS56135419A (en) | 1980-03-27 | 1980-03-27 | Preventive and improver for radiation disorder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3823580A JPS56135419A (en) | 1980-03-27 | 1980-03-27 | Preventive and improver for radiation disorder |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56135419A true JPS56135419A (en) | 1981-10-22 |
JPS6241569B2 JPS6241569B2 (enrdf_load_stackoverflow) | 1987-09-03 |
Family
ID=12519630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3823580A Granted JPS56135419A (en) | 1980-03-27 | 1980-03-27 | Preventive and improver for radiation disorder |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56135419A (enrdf_load_stackoverflow) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100330054A1 (en) * | 2007-10-11 | 2010-12-30 | Fayrefield Foods Limited | Preparation, use of preparation for treatment, and method of treatment of intestinal infection |
-
1980
- 1980-03-27 JP JP3823580A patent/JPS56135419A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100330054A1 (en) * | 2007-10-11 | 2010-12-30 | Fayrefield Foods Limited | Preparation, use of preparation for treatment, and method of treatment of intestinal infection |
Also Published As
Publication number | Publication date |
---|---|
JPS6241569B2 (enrdf_load_stackoverflow) | 1987-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kohwi et al. | Antitumor effect of Bifidobacterium infantis in mice | |
Reddy et al. | Antitumor activity of yogurt components | |
Riggio et al. | Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients | |
CA2099855C (en) | Antigastritis agent | |
Sanders | Lactic acid bacteria as promoters of human health | |
Guarner | Inulin and oligofructose: impact on intestinal diseases and disorders | |
Bolognani et al. | Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens | |
Cunningham-Rundles et al. | Probiotics and immune response | |
JP3984546B2 (ja) | プロバイオティックスの組合せ | |
Kolida et al. | Prebiotic effects of inulin and oligofructose | |
Taper et al. | Possible adjuvant cancer therapy by two prebiotics-inulin or oligofructose | |
Voorhess et al. | URINARY EXCRETION OF NOREPINEPHRINE, EPINEPHRINE AND 3-METHOXY-4-HYDROXYMANDELIC ACID BY CHILDREN WITH NEURO-BLASTOMA | |
Dubey et al. | Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas | |
EP1112692A1 (en) | Drinks and foods capable of eliminating i helicobacter pylori /i | |
Cole et al. | Effect of Probiotic Supplements of Lactobacillus acidophilus and Bifidobacterium adolescentis 2204 on β-glueosidase and β-glueuronidase Activity in the Lower Gut of Rats Associated with a Human Faecal Flora | |
Parodi | The role of intestinal bacteria in the causation and prevention of cancer: modulation by diet and probiotics | |
Midtvedt et al. | Conversion of cholesterol to coprostanol by the intestinal microflora during the first two years of human life | |
PT1649760E (pt) | Composição contendo uma bactéria de ácido láctico produzindo equol | |
US5895758A (en) | Strain of lactobacillus Plantarum | |
Yamazaki et al. | The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. | |
JP4712289B2 (ja) | 免疫促進用組成物 | |
Adachi | Lactic acid bacteria and the control of tumours | |
Herich et al. | The effect of Lactobacillus paracasei and Raftilose P95 upon the non-specific immune response of piglets | |
JPS56135419A (en) | Preventive and improver for radiation disorder | |
KR20220008218A (ko) | 염증성 장질환 예방 또는 치료용 조성물 |